DS
STAB

David Shaw’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

David Shaw’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,352
Closed -$31K – 4330
2014
Q3 		$31K Hold
3,352
– – ﹤0.01% 4034
2014
Q2 		$32K Hold
3,352
– – ﹤0.01% 4122
2014
Q1 		$46K Sell
3,352
-215
-6% -$3.5K ﹤0.01% 4204
2013
Q4 		$83K Hold
3,567
– – ﹤0.01% 4381
2013
Q3 		$111K Hold
3,567
– – ﹤0.01% 4179
2013
Q2 		$113K Buy
+3,567
New +$123K ﹤0.01% 3860

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 374.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

David Shaw's STAB Position: Q4 2014 in Review

David Shaw sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2014, closing a stake of 3,352 shares — an estimated $31K sold.

David Shaw first reported a position in STAB in Q2 2013 and held it in 6 quarters. The position peaked at $113K in Q2 2013. 24 funds tracked by Wall St. Rank hold STAB as of Q4 2014.

  • David Shaw reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • David Shaw sold 3,352 Statera Biopharma, Inc. Common Stock shares in Q4 2014, an estimated $31K.
  • David Shaw first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 6 quarters.
  • David Shaw's Statera Biopharma, Inc. Common Stock position peaked at $113K in Q2 2013.
  • 24 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2014.

Based on D.E. Shaw & Co's 13F filing for Q4 2014, filed 17 Feb 2015.